Partner
Chartered Patent Attorney
European Patent Attorney
UK Design Attorney
BSc Biochemistry, University College London
PhD Molecular and Developmental Biology, University of Cambridge
Thank you
Dev represents biotech and chemicals clients based in the UK, Europe, and US. He joined the patent profession in the late 1990s at the time of the first biotech boom. Since joining Keltie in 2004 he has developed a thriving international practice specialising in providing strategic advice and support for early stage and rapid growth technology companies particularly in the fields of biological therapeutics, synthetic biology, computational biology & bioinformatics and medical devices. Dev enjoys working closely with clients to help counsel them in devising robust intellectual property strategies through serial funding rounds. He has worked with many clients that have successfully exited by trade sale, or through IPOs on the London Stock Exchange as well as NASDAQ.
His work involves the development of valuable patent positions in competitive global markets, as well as freedom-to-operate and patent landscape analysis. He advises on contentious issues and handles oppositions before the European Patent Office. In 2014 he successfully defended Freedom Innovations' Patent in an opposition referral to the EPO Enlarged Board of Appeal (G3/14).
Dev is a member of the Life Sciences Committee of the Chartered Institute of Patent Attorneys and regularly publishes and presents in the field of biotechnology intellectual property law.
What people think about Devanand
Dev is an IAM Global Leader 2022 for intellectual property in the United Kingdom.
The IAM Patent 1000 2022 edition says: in the words of one happy customer: “You can count on Dev to have your best interests in mind when detailing your IP, with a strong understanding of where you are as a company, your financial resources and where you want to go commercially with your idea. This balance I have struggled to find elsewhere and for me is what sets Dev apart from other IP attorneys.”
The IAM Patent 1000 2020 edition states that Dev “has made an impression on peers with his “vast understanding of biochemistry and other life science fields”. With expertise in genomics, epigenetics and medical devices, he provides shrewd strategic guidance and support to companies across the United Kingdom, the United States and Asia”.
The IAM Patent 1000 2018 states that Dev's "doctorate in molecular biology and his technical training make him an ideal advocate for effectively and efficiently obtaining key European patents for biotech clients. He is knowledgeable, diligent, responsive to clients' needs and an excellent team player. He really is a patent strategist rather than simply a filer".
Dev has also been listed in Who's Who Legal every year since 2016.
15.05.2023
Jonathan Goodacre promoted to PartnerKeltie is delighted to announce that Dr Jonathan Goodacre is a partner of the firm as of 1st May 2023.
24.08.2020
Working with start-ups – interview with Dev Crease.Dev Crease joined Keltie in 2004 just after he qualified as a UK and European patent attorney. Over past 16 years he has developed a thriving practice in the life sciences, chemical and medical technologies team based around advising rapid growth companies achieve value in their IP positions.
08.03.2021
Materials and the power of a nameOtherLess related knowledge
Thank you
